TRUE AXIS BIO
MOTS‑c
- CAS Number
- 1627580-64-6
- Molecular Formula
- C101H152N28O22S2
- Molecular Weight
- 2174.6 g/mol
FOR RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTION
TRUE AXIS BIO
CJC‑1295 With DAC
- CAS Number
- 446262-90-4
- Molecular Formula
- C165H269N47O46
- Molecular Weight
- 3647.2 g/mol
FOR RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTION
CJC-1295 With DAC
For research use only. Not for human consumption.
For Research Use Only (RUO). Not for human or animal consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Purchaser must meet all applicable age requirements.
SKU:
Plain-English Summary
Research Overview
- What It Is
- CJC-1295 With DAC is a research peptide studied for its interaction with growth-hormone-related signaling. The DAC modification is designed to help the peptide remain present longer than shorter-acting GHRH-related compounds.
- Explanation
- CJC-1295 With DAC is designed to copy a natural signal involved in growth hormone release.
The DAC portion helps extend how long the peptide remains available in a research setting. This is the main difference between CJC-1295 With DAC and shorter-acting versions made without DAC. - Why It’s Researched
- Researchers study CJC-1295 With DAC to better understand growth-hormone signaling, IGF-1-related activity, peptide stability, and the effects of extending a peptide’s activity through albumin binding.
Research may also compare the longer-acting DAC version with shorter-acting GHRH-related compounds. - Storage Instructions
- Store and handle according to the instructions provided with the applicable batch documentation. Protect the material from excessive heat, light, moisture, and contamination. Maintain appropriate laboratory records for receipt, storage, handling, and disposal. For laboratory research only.
Once reconstituted, store at the verified temperature specified for the exact product or formulation when such guidance is available.
Product-Specific Information
Scientific Details
- Scientific Context
- Growth hormone-releasing hormone, often shortened to GHRH, is part of the signaling system connected to growth hormone release.
CJC-1295 With DAC was created to act on this same research pathway while remaining available longer than naturally occurring GHRH and shorter-acting related peptides.
The DAC modification allows the compound to associate with albumin, a protein naturally present in blood. Researchers study how this modification changes the peptide’s stability, duration, and signaling activity.
CJC-1295 With DAC is different from CJC-1295 Without DAC. The two should not be treated as interchangeable research materials.
Mechanism Snapshot
Targets & Pathways
- Common Research Areas
- • Growth-hormone-related signaling
• GHRH receptor research
• IGF-1-related activity
• Peptide stability and persistence
• Albumin-binding peptide technology
• Endocrine signaling
• Comparison of DAC and non-DAC GHRH-related peptides
RELATED PRODUCTS
TRUE AXIS BIO
TRUE AXIS BIO
GLP3
- CAS Number
- 2381089-83-2
- Molecular Formula
- C221H342N46O68
- Molecular Weight
- 4731.34 g/mol
FOR RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTION
TRUE AXIS BIO
NAD
- CAS Number
- 53-84-9
- Molecular Formula
- C21H27N7O14P2
- Molecular Weight
- 663.4 g/mol
FOR RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTION
TRUE AXIS BIO
Ipamorelin
- CAS Number
- 170851-70-4
- Molecular Formula
- C38H49N9O5
- Molecular Weight
- 711.9 g/mol
FOR RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTION